PATENT CLAIM ANALYSIS

Application Number: 15990576
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "230500"]

Abstract:
The present invention relates to substituted heterocyclic derivative compounds, compositions comprising said compounds, and the use of said compounds and compositions for epigenetic regulation by inhibition of bromodomain-mediated recognition of acetyl lysine regions of proteins, such as histones. Said compositions and methods are useful for the treatment of cancer and neoplastic disease.

Claim (Index 16):
The compound of  claim 10 , wherein Q is C and T is N.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.425
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14517705', '15870557', '14789881', '14658048', '15488674']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.851562361687755
- 35 USC 102 Novelty (BERT): 0.5630502404073957
- Combined Prediction Score: 0.8227111495597191
- Mean Citation Score: 497.6735259999999
- Max Citation Score: 580.4232
- Similarity Product: 309.7248743828773

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test